Global Pharmaceuticals & Biotech Mid-Large Cap Stocks

Zai Lab

Market Cap: US$3.5b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

Protagonist Therapeutics

Market Cap: US$2.9b

A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.

Aurinia Pharmaceuticals

Market Cap: US$1.1b

A biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs.

Verona Pharma

Market Cap: US$6.8b

A biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs.

Kymera Therapeutics

Market Cap: US$2.0b

A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.

Avidity Biosciences

Market Cap: US$3.8b

A biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs).

Edgewise Therapeutics

Market Cap: US$1.6b

A biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders.

Twist Bioscience

Market Cap: US$1.9b

Manufactures and sells synthetic DNA-based products.

Immunovant

Market Cap: US$2.5b

A clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases.

ChemoMetec

Market Cap: DKK 9.2b

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.

Alkermes

Market Cap: US$5.2b

A biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.

Crinetics Pharmaceuticals

Market Cap: US$2.9b

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Biohaven

Market Cap: US$1.7b

Biohaven Ltd. discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology worldwide.

Nuvalent

Market Cap: US$5.4b

A clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.

Sotera Health

Market Cap: US$3.6b

Provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

Charles River Laboratories International

Market Cap: US$7.0b

Charles River Laboratories International, Inc.

Alvotech

Market Cap: US$3.0b

Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.

Agios Pharmaceuticals

Market Cap: US$1.7b

A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.

Apellis Pharmaceuticals

Market Cap: US$2.3b

A commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs.

Natera

Market Cap: US$21.1b

A diagnostics company, provides molecular testing services worldwide.

Amneal Pharmaceuticals

Market Cap: US$2.3b

A global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide.

10x Genomics

Market Cap: US$1.1b

A life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific.

MiMedx Group

Market Cap: US$1.1b

Develops and distributes placental tissue allografts for various sectors of healthcare.

Regencell Bioscience Holdings

Market Cap: US$5.8b

Operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.

Scholar Rock Holding

Market Cap: US$3.0b

A biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.

MannKind

Market Cap: US$1.3b

A biopharmaceutical company, focuses on the development and commercialization of therapeutic products and services for endocrine and orphan lung diseases in the United States.

Legend Biotech

Market Cap: US$5.2b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Endo

Market Cap: US$1.6b

A specialty pharmaceutical company, develops, manufactures, markets, and sells various pharmaceutical products in the United States and internationally.

CRISPR Therapeutics

Market Cap: US$3.4b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

Telix Pharmaceuticals

Market Cap: AU$8.7b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals for cancer and rare diseases in Australia, Belgium, Japan, Switzerland, and the United States.

Mesoblast

Market Cap: AU$2.2b

Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.

Moderna

Market Cap: US$10.8b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

Recursion Pharmaceuticals

Market Cap: US$1.9b

Operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States.